DE1493824A1 - Verfahren zur Herstellung von Aminocarbonsaeureamiden - Google Patents

Verfahren zur Herstellung von Aminocarbonsaeureamiden

Info

Publication number
DE1493824A1
DE1493824A1 DE19641493824 DE1493824A DE1493824A1 DE 1493824 A1 DE1493824 A1 DE 1493824A1 DE 19641493824 DE19641493824 DE 19641493824 DE 1493824 A DE1493824 A DE 1493824A DE 1493824 A1 DE1493824 A1 DE 1493824A1
Authority
DE
Germany
Prior art keywords
acid
amide
phenyl
amphetamine
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19641493824
Other languages
German (de)
English (en)
Inventor
Hellerbach Dr Joseph
Vogler Dr Karl
Quitt Dr Peter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE1493824A1 publication Critical patent/DE1493824A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19641493824 1964-01-27 1964-11-23 Verfahren zur Herstellung von Aminocarbonsaeureamiden Pending DE1493824A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH93064 1964-01-27

Publications (1)

Publication Number Publication Date
DE1493824A1 true DE1493824A1 (de) 1969-05-22

Family

ID=4198470

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19641493824 Pending DE1493824A1 (de) 1964-01-27 1964-11-23 Verfahren zur Herstellung von Aminocarbonsaeureamiden

Country Status (5)

Country Link
BE (1) BE658748A (enExample)
DE (1) DE1493824A1 (enExample)
ES (1) ES308571A1 (enExample)
FR (1) FR1421130A (enExample)
NL (1) NL6414901A (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120157706A1 (en) * 2010-12-20 2012-06-21 Bauer Michael J Methods and Compositions for Preparing Lisdexamfetamine and Salts Thereof
EP2560486A4 (en) * 2010-04-21 2014-09-17 Signature Therapeutics Inc COMPOSITIONS OF ENZYMSPALTBAR AMPHETAMINE PRODRUGS AND INHIBITORS THEREFOR
US12384744B2 (en) 2021-09-29 2025-08-12 Ensysce Biosciences Inc. Enzyme-cleavable methadone prodrugs and methods of use thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
WO2005032474A2 (en) 2003-09-30 2005-04-14 New River Pharmaceuticals Inc. Pharmaceutical compositions for prevention of overdose or abuse
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US7700561B2 (en) * 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
EP1531844B1 (en) * 2002-02-22 2014-08-20 Shire LLC Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances
US7659253B2 (en) 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
NZ544162A (en) * 2003-05-29 2008-09-26 Shire Llc Abuse resistant amphetamine compounds
BRPI0720105A2 (pt) 2006-12-11 2014-10-07 Kempharm Inc Conjugados de aminoácido não padrões de anfetamina e processos para fabricação e uso dos mesmos
ES2806995T3 (es) * 2017-09-20 2021-02-19 Sandoz Ag Sales cristalinas de un profármaco de dextroanfetamina

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2560486A4 (en) * 2010-04-21 2014-09-17 Signature Therapeutics Inc COMPOSITIONS OF ENZYMSPALTBAR AMPHETAMINE PRODRUGS AND INHIBITORS THEREFOR
US11179355B2 (en) 2010-04-21 2021-11-23 Signature Therapeutics, Inc. Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof
US11400062B2 (en) 2010-04-21 2022-08-02 Signature Therapeutics, Inc. Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof
US20120157706A1 (en) * 2010-12-20 2012-06-21 Bauer Michael J Methods and Compositions for Preparing Lisdexamfetamine and Salts Thereof
US8779191B2 (en) * 2010-12-20 2014-07-15 Cambrex Charles City, Inc. Methods and compositions for preparing lisdexamfetamine and salts thereof
US12384744B2 (en) 2021-09-29 2025-08-12 Ensysce Biosciences Inc. Enzyme-cleavable methadone prodrugs and methods of use thereof

Also Published As

Publication number Publication date
FR1421130A (fr) 1965-12-10
ES308571A1 (es) 1966-06-01
NL6414901A (enExample) 1965-07-28
BE658748A (enExample) 1965-07-26

Similar Documents

Publication Publication Date Title
DE1493824A1 (de) Verfahren zur Herstellung von Aminocarbonsaeureamiden
DE2947140C2 (enExample)
EP0608759B1 (de) Piperazinderivate
DE1695897A1 (de) N-Acyl-sydnonimin-Derivate
DE4443390A1 (de) Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten
CH663019A5 (de) N-acylierte diamidderivate saurer aminosaeuren, deren salze oder solvate, verfahren zur herstellung derselben und anti-ulcus-mittel.
DE2515146A1 (de) Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3213027A1 (de) 2,3-disubstituiertes 5,6-dihydroimidazo (2,1-b) thiazol, dessen salze, verfahren zu dessen bzw. deren herstellung und dieses bzw. diese enthaltendes entzuendungshemmendes mittel
EP0564499B1 (de) Neue amine, verfahren zu ihrer herstellung, sowie diese verbindungen enthaltende arzneimittel
DE1643416A1 (de) Verfahren zur Herstellung von Phenylalaninderivaten
DE2819457C3 (de) L- oder DL-Phenylglycin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH473087A (de) Verfahren zur Herstellung von 2-Niederalkoxy-4-nitro-benzylamin
DE2064061A1 (de) Neue tuberkulostatisch wirkende alpha-aminoxy-carbonsaeureamid-derivate und verfahren zur herstellung derselben
DE2038919A1 (de) Neue 3-Amino-delta?-pyrazolinderivate und Verfahren zur Herstellung derselben
AT345290B (de) Verfahren zur herstellung neuer substituierter alfa-aminooxycarbonsaeurehydrazidderivate und ihrer salze
DE3248431A1 (de) Ester von 4-hydroxymethyl-1-phtalazon-derivaten und deren salze sowie ein verfahren zu ihrer herstellung
AT215997B (de) Verfahren zur Herstellung neuer Ester der α-Phenyl-α-piperidyl-(2)-essigsäure
AT367029B (de) Verfahren zur herstellung von neuen racemischen oder optisch aktiven phenylessigsaeureamiden
DE1445629C (de) Neue Piperazinderivate
AT211296B (de) Verfahren zur Herstellung von neuen Sulfamylanthranilsäuren
AT234685B (de) Verfahren zur Herstellung neuer 3-Phenyl-sydnonimine
AT205474B (de) Verfahren zur Herstellung von substituierten Aminosäurehydraziden
DE2551483A1 (de) Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
AT266120B (de) Verfahren zur Herstellung von neuen Diazahydrindan- und Pyridopyrimidinderivaten und ihren Salzen
AT234663B (de) Verfahren zur Herstellung von substituierten Hydrazinverbindungen und deren Salzen